Track Lytix Biopharma AS's current assets ($74M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Lytix Biopharma AS (LYTIX.OL) currently reports a current assets of $74M as of September 2026. That compares with $93M in the prior-year period — down 20.1% year over year. Use the charts on this page to explore Lytix Biopharma AS's current assets history and peer comparisons.
Lytix Biopharma AS's current assets decreased from $93M to $74M — a 20.1% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Lytix Biopharma AS reported $74M in current assets as of September 2026. That compares with $93M in the prior-year period — down 20.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $74M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lytix Biopharma AS, and consider following LYTIX.OL for alerts when major investors trade the stock.
Lytix Biopharma AS is classified in the Healthcare sector. On current assets, it currently shows $74M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LYTIX.OL with unrelated industries.